Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 15542 monohydrÁt pramipexol-dihydrochloridu - tableta s prodlouženým uvolňováním - 0,26mg - pramipexol

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 15542 monohydrÁt pramipexol-dihydrochloridu - tableta s prodlouženým uvolňováním - 0,52mg - pramipexol

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 15542 monohydrÁt pramipexol-dihydrochloridu - tableta s prodlouženým uvolňováním - 2,1mg - pramipexol

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

teva pharmaceuticals cr, s.r.o., praha array - 14774 aripiprazol - tableta - 10mg - aripiprazol

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

teva pharmaceuticals cr, s.r.o., praha array - 14774 aripiprazol - tableta - 15mg - aripiprazol

Eiropas Savienība - čehu - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Eiropas Savienība - čehu - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - léky užívané při diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Eiropas Savienība - čehu - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 14838 donepezil-hydrochlorid - tableta dispergovatelná v ústech - 10mg - donepezil

Čehija - čehu - SUKL (Státní ústav pro kontrolu léčiv)

sandoz s.r.o., praha array - 14838 donepezil-hydrochlorid - tableta dispergovatelná v ústech - 10mg - donepezil